In breast cancer, the single-cell profiling of docetaxel-resistant MCF7 breast cancer cells revealed a subset of cells with a stem-like phenotype and identified LEF1 as the critical molecule regulator in drug resistance (99). This evidence concerns the gene LEF1 and breast carcinoma.